Overview

CC-4047 (Pomalidomide) for Graft vs. Host Disease

Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This study will test the safety and effectiveness CC-4047 (pomalidomide) in patients with advanced, steroid refractory graft-versus-host disease.
Phase:
Phase 2
Details
Lead Sponsor:
Washington University School of Medicine
Treatments:
Pomalidomide
Thalidomide